Spyre Therapeutics Stock Price on June 3, 2024
| SYRE Stock | 27.75 0.08 0.29% |
Below is the normalized historical share price chart for Spyre Therapeutics extending back to April 07, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spyre Therapeutics stands at 27.75, as last reported on the 28th of November, with the highest price reaching 28.23 and the lowest price hitting 27.23 during the day.
If you're considering investing in Spyre Stock, it is important to understand the factors that can impact its price. At this point, Spyre Therapeutics is not too volatile. Spyre Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0032, which indicates the firm had a 0.0032% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Spyre Therapeutics, which you can use to evaluate the volatility of the company. Please validate Spyre Therapeutics' Semi Deviation of 4.0, risk adjusted performance of 0.0211, and Coefficient Of Variation of 5815.02 to confirm if the risk estimate we provide is consistent with the expected return of 0.0119%.
At present, Spyre Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 801.4 M, whereas Total Stockholder Equity is forecasted to decline to about 96.1 M. . At present, Spyre Therapeutics' Price Sales Ratio is projected to increase significantly based on the last few years of reporting. Spyre Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of April 2016 | 200 Day MA 31.3702 | 50 Day MA 31.1579 | Beta 2.91 |
Spyre |
Sharpe Ratio = 0.0032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SYRE |
Estimated Market Risk
| 3.67 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spyre Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spyre Therapeutics by adding Spyre Therapeutics to a well-diversified portfolio.
Price Book 9.4952 | Enterprise Value Ebitda (7.96) | Price Sales 2.2 K | Shares Float 32.8 M | Wall Street Target Price 58.625 |
Related Headline
Lumos Pharma Headline on 3rd of June 2024
Disposition of 25500 shares by Pitukcheewanont Pisit Duke of... by Pitukcheewanont Pisit Duke
Filed transaction by Lumos Pharma Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Spyre Therapeutics Valuation on June 3, 2024
It is possible to determine the worth of Spyre Therapeutics on a given historical date. On June 3, 2024 Spyre was worth 35.0 at the beginning of the trading date compared to the closed value of 36.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Spyre Therapeutics stock. Still, in general, we apply an absolute valuation method to find Spyre Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spyre Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Spyre Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 34.45 | 35.83 | 34.13 | 34.95 | 393,781 | |
06/03/2024 | 35.00 | 37.50 | 34.09 | 36.79 | 312,668 |
| 36.58 | 37.30 | 33.05 | 34.10 | 546,704 |
| Backtest Spyre Therapeutics | | | Spyre Therapeutics History | | | Spyre Therapeutics Valuation | Previous | Next |
Spyre Therapeutics Trading Date Momentum on June 3, 2024
| On June 04 2024 Spyre Therapeutics was traded for 34.10 at the closing time. The top price for the day was 37.30 and the lowest listed price was 33.05 . The trading volume for the day was 546.7 K. The trading history from June 4, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 7.31% . The trading price change against the current closing price is 0.05% . |
Spyre Therapeutics Fundamentals Correlations and Trends
By evaluating Spyre Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Spyre Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Spyre financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Spyre Therapeutics Stock history
Spyre Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spyre is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spyre Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spyre Therapeutics stock prices may prove useful in developing a viable investing in Spyre Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.9 M | 7.2 M |
Spyre Therapeutics Quarterly Net Working Capital |
|
Spyre Therapeutics Stock Technical Analysis
Spyre Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Spyre Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Spyre Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Spyre Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Spyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spyre Therapeutics shares will generate the highest return on investment. By undertsting and applying Spyre Therapeutics stock market strength indicators, traders can identify Spyre Therapeutics entry and exit signals to maximize returns
Spyre Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spyre Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spyre Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spyre to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0211 | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.0226 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Spyre Stock analysis
When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world |